Literature DB >> 3602356

An animal model of pulmonary radiation fibrosis with biochemical, physiologic, immunologic, and morphologic observations.

R L Karvonen, F Fernandez-Madrid, R L Maughan, K C Palmer, I Fernandez-Madrid.   

Abstract

An animal model of pulmonary radiation fibrosis was established, using male CBA/j mice. Both lungs of each mouse in one group (DL) were irradiated with two doses of 8.5 Gy each, separated by 30 days. A control group (CG) was sham-irradiated. There was a small but significant difference (P less than 0.03) in average breathing rate between DL and CG 27 weeks after the second irradiation which increased until the 34th week followed by a plateau. The accumulated hydroxyproline content of the irradiated mouse lung was 40% greater (P less than 0.02) than that of the sham-irradiated lung at 42 weeks and thereafter. Anticollagen antibodies assayed 52 weeks after irradiation by enzyme-linked immunosorbent assay were elevated by 49% in sera from the irradiated mice compared to sera from sham-irradiated mice. Mortality during the 52-week period following the second irradiation was low (13%) for both groups. Histological comparison of irradiated and control mouse lungs fixed under uniform inflation pressure indicated no significant differences. The model has unique features including an increase in collagen deposition, no acute changes attributable to radiation, a small but statistically significant abnormality in pulmonary function, an immunologic response to collagen, and low mortality.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3602356

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

Review 1.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

2.  Dependence of proteoglycan induced arthritis in BALB/c mice on the development of autoantibodies to high density proteoglycans.

Authors:  P H Wooley; S W Siegner; J D Whalen; R L Karvonen; F Fernández-Madrid
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

Review 3.  Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.

Authors:  Jun Tashiro; Gustavo A Rubio; Andrew H Limper; Kurt Williams; Sharon J Elliot; Ioanna Ninou; Vassilis Aidinis; Argyrios Tzouvelekis; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2017-07-28

Review 4.  Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis.

Authors:  Alejandro Egea-Zorrilla; Laura Vera; Borja Saez; Ana Pardo-Saganta
Journal:  Cells       Date:  2022-08-20       Impact factor: 7.666

Review 5.  Radiation-Induced Lung Fibrosis: Preclinical Animal Models and Therapeutic Strategies.

Authors:  Hee Jin; Youngjo Yoo; Younghwa Kim; Yeijin Kim; Jaeho Cho; Yun-Sil Lee
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.